Cargando…

Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil

BACKGROUND: Brazil is one of top 10 countries with the highest number of people with diabetes mellitus (DM), affecting 16.8 million peoples. It is estimated that 7.7 million people (20–79 years) in the country have not yet been diagnosed, representing an under-diagnosis rate of 46.0%. Herein we aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Correr, Cassyano J., Coura-Vital, Wendel, Frade, Josélia C. Q. P., Nascimento, Renata C. R. M., Nascimento, Lúbia G., Pinheiro, Eliete B., Ferreira, Wesley M., Reis, Janice S., Melo, Karla F. S., Pontarolo, Roberto, Lenzi, Mônica S. A., Almeida, José V., Pedrosa, Hermelinda C., João, Walter S. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545923/
https://www.ncbi.nlm.nih.gov/pubmed/33062060
http://dx.doi.org/10.1186/s13098-020-00593-5
_version_ 1783592130513469440
author Correr, Cassyano J.
Coura-Vital, Wendel
Frade, Josélia C. Q. P.
Nascimento, Renata C. R. M.
Nascimento, Lúbia G.
Pinheiro, Eliete B.
Ferreira, Wesley M.
Reis, Janice S.
Melo, Karla F. S.
Pontarolo, Roberto
Lenzi, Mônica S. A.
Almeida, José V.
Pedrosa, Hermelinda C.
João, Walter S. J.
author_facet Correr, Cassyano J.
Coura-Vital, Wendel
Frade, Josélia C. Q. P.
Nascimento, Renata C. R. M.
Nascimento, Lúbia G.
Pinheiro, Eliete B.
Ferreira, Wesley M.
Reis, Janice S.
Melo, Karla F. S.
Pontarolo, Roberto
Lenzi, Mônica S. A.
Almeida, José V.
Pedrosa, Hermelinda C.
João, Walter S. J.
author_sort Correr, Cassyano J.
collection PubMed
description BACKGROUND: Brazil is one of top 10 countries with the highest number of people with diabetes mellitus (DM), affecting 16.8 million peoples. It is estimated that 7.7 million people (20–79 years) in the country have not yet been diagnosed, representing an under-diagnosis rate of 46.0%. Herein we aimed to screen people for high blood glucose or risk for developing type 2 DM (T2DM) through community pharmacies in Brazil. METHODS: A cross-sectional study was carried out in November 2018, involving 977 pharmacists from 345 municipalities in Brazil. The study evaluated people between 20 and 79 years old without a previous diagnosis of DM. Glycemia was considered high when its value was ≥ 100 mg/dL fasting and ≥ 140 mg/dL in a casual feeding state. The FINDRISC (Finnish Diabetes Risk Score) was used to estimate the risk for developing T2DM. The prevalence of high blood glucose was estimated and the associated factors were obtained using Poisson's multivariate analysis with robust variance. RESULTS: During the national screening campaign, 17,580 people were tested with the majority of the consultations (78.2%) being carried out in private pharmacies. The population was composed mainly of women (59.5%) and people aged between 20 and 45 years (47.9%). The frequency of participants with high blood glucose was 18.4% (95% CI 17.9–19.0). Considering the FINDRISC, 22.7% of people had a high or very high risk for T2DM. The risk factors associated with high blood glucose were: Body Mass Index > 25 kg/m(2), abdominal circumference > 94 cm for men and > 80 cm for women; education level below 15 years of study, no daily intake of vegetables and fruits; previous diagnosis of arterial hypertension; history of high blood glucose and family history of DM. CONCLUSIONS: This is the largest screening study that evaluated the frequency of high blood glucose and its associated factors in a population without a previous diagnosis ever performed in community pharmacies in Brazil. These results may help to improve public health policies and reinforce the role of pharmacists in screening and education actions aimed at this undiagnosed population in a continent-size country such as Brazil.
format Online
Article
Text
id pubmed-7545923
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75459232020-10-13 Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil Correr, Cassyano J. Coura-Vital, Wendel Frade, Josélia C. Q. P. Nascimento, Renata C. R. M. Nascimento, Lúbia G. Pinheiro, Eliete B. Ferreira, Wesley M. Reis, Janice S. Melo, Karla F. S. Pontarolo, Roberto Lenzi, Mônica S. A. Almeida, José V. Pedrosa, Hermelinda C. João, Walter S. J. Diabetol Metab Syndr Research BACKGROUND: Brazil is one of top 10 countries with the highest number of people with diabetes mellitus (DM), affecting 16.8 million peoples. It is estimated that 7.7 million people (20–79 years) in the country have not yet been diagnosed, representing an under-diagnosis rate of 46.0%. Herein we aimed to screen people for high blood glucose or risk for developing type 2 DM (T2DM) through community pharmacies in Brazil. METHODS: A cross-sectional study was carried out in November 2018, involving 977 pharmacists from 345 municipalities in Brazil. The study evaluated people between 20 and 79 years old without a previous diagnosis of DM. Glycemia was considered high when its value was ≥ 100 mg/dL fasting and ≥ 140 mg/dL in a casual feeding state. The FINDRISC (Finnish Diabetes Risk Score) was used to estimate the risk for developing T2DM. The prevalence of high blood glucose was estimated and the associated factors were obtained using Poisson's multivariate analysis with robust variance. RESULTS: During the national screening campaign, 17,580 people were tested with the majority of the consultations (78.2%) being carried out in private pharmacies. The population was composed mainly of women (59.5%) and people aged between 20 and 45 years (47.9%). The frequency of participants with high blood glucose was 18.4% (95% CI 17.9–19.0). Considering the FINDRISC, 22.7% of people had a high or very high risk for T2DM. The risk factors associated with high blood glucose were: Body Mass Index > 25 kg/m(2), abdominal circumference > 94 cm for men and > 80 cm for women; education level below 15 years of study, no daily intake of vegetables and fruits; previous diagnosis of arterial hypertension; history of high blood glucose and family history of DM. CONCLUSIONS: This is the largest screening study that evaluated the frequency of high blood glucose and its associated factors in a population without a previous diagnosis ever performed in community pharmacies in Brazil. These results may help to improve public health policies and reinforce the role of pharmacists in screening and education actions aimed at this undiagnosed population in a continent-size country such as Brazil. BioMed Central 2020-10-08 /pmc/articles/PMC7545923/ /pubmed/33062060 http://dx.doi.org/10.1186/s13098-020-00593-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Correr, Cassyano J.
Coura-Vital, Wendel
Frade, Josélia C. Q. P.
Nascimento, Renata C. R. M.
Nascimento, Lúbia G.
Pinheiro, Eliete B.
Ferreira, Wesley M.
Reis, Janice S.
Melo, Karla F. S.
Pontarolo, Roberto
Lenzi, Mônica S. A.
Almeida, José V.
Pedrosa, Hermelinda C.
João, Walter S. J.
Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title_full Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title_fullStr Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title_full_unstemmed Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title_short Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
title_sort prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545923/
https://www.ncbi.nlm.nih.gov/pubmed/33062060
http://dx.doi.org/10.1186/s13098-020-00593-5
work_keys_str_mv AT corrercassyanoj prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT couravitalwendel prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT fradejoseliacqp prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT nascimentorenatacrm prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT nascimentolubiag prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT pinheiroelieteb prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT ferreirawesleym prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT reisjanices prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT melokarlafs prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT pontaroloroberto prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT lenzimonicasa prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT almeidajosev prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT pedrosahermelindac prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil
AT joaowaltersj prevalenceofpeopleatriskofdevelopingtype2diabetesmellitusandtheinvolvementofcommunitypharmaciesinanationalscreeningcampaignapioneeractioninbrazil